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Osteosarcoma is the most common malignant pri-
mary bone tumour, arising predominantly in the 
femur, tibia, and humerus.1-3 The current man-
agement of high-grade osteosarcoma is limb sal-
vage combined with neoadjuvant and adjuvant 
chemotherapy.4,5 This approach has significantly 
improved the long-term survival and limb salvage 
rates throughout the last decades,6-9 and has also 
contributed to the development of different sur-
gical techniques.10-12 However, there is still con-
troversy regarding which are the most appropriate 
surgical strategies after neoadjuvant chemotherapy 
when the tumour involves the main vasculature of 
the limb.13,14
To date, a variety of clinical studies have 
attempted to identify prognostic factors for local 
recurrence (LR) and survival in patients with 
osteosarcoma following neoadjuvant treatment. 
The prognostic factors for survival include age,8 
sex,15 tumour location,16 tumour size,8,15 type of 
surgery,17,18 presence of LR,18 surgical margin,8,16 
and tumour response to neoadjuvant chemo-
therapy,8,16,17,19,20 the last two factors influenc-
ing LR-free survival (LRFS).21,22 However, the 
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Aims
The aim of this study was to determine the risk of local recurrence and survival in patients 
with osteosarcoma based on the proximity of the tumour to the major vessels.
Patients and Methods
A total of 226 patients with high-grade non-metastatic osteosarcoma in the limbs were 
investigated. Median age at diagnosis was 15 years (4 to 67) with the ratio of male 
to female patients being 1.5:1. The most common site of the tumour was the femur 
(n = 103) followed by tibia (n = 66). The vascular proximity was categorized based on 












limited vascular attachment to less than half circumference or longitudinal 10 mm reduced 
the risk of local recurrence.
Conclusion
The proximity of osteosarcoma to major blood vessels is a poor prognostic factor for local 
control and survival. Amputation offers better local control for tumours attached to the 
blood vessels but does not improve survival. Limb salvage surgery offers similar local 
control if the tumour attachment to blood vessels is limited.
Cite this article: Bone Joint J 2019;101-B:1024–1031.
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correlation between the vascular proximity to the tumour and 
the surgical outcomes has been unclear.
Recently, the Birmingham Classification was reported.23 
This method introduced a new concept of margins based on the 
distance in millimetres from the tumour to the resected normal 
tissue and provided a postoperative stratification of the prog-
nosis based on the response to chemotherapy and margin. One 
of the advantages of this system is the more reproducible and 
reliable evaluation of the surgical margins, in contrast with that 
of Enneking et al.24 However, the Birmingham Classification 
does not permit preoperative predictions in order to select the 
best surgical alternative. Thus, a complementary preoperative 
assessment tool is still required.
The aim of this study was to analyze the risk of LR and sur-
vival depending on the proximity of the tumour to the main 
vascular structures, in patients presenting with high-grade oste-
osarcoma in the limbs. The following clinical questions were 
asked: 1) does the vascular proximity modify the survival or 
the risk of LR?; 2) how safe is limb salvage when the tumour 
is close to or attached to the major vessels?; and 3) what is the 
actual microscopic margin in patients with limb salvage when 
the tumour is attached to the major vascular bundles on preop-
erative MRI?
Patients and Methods
Eligibility. This study included all patients with a diagnosis 
of a primary osteosarcoma treated between January 2007 and 
December 2015 at our institution. The inclusion criteria were 
a diagnosis of high-grade osteosarcoma located in the limbs, 
and a minimum of two years’ follow-up for survivors. A total 
of 343 eligible cases were identified. Patients were excluded if 
they presented with metastasis at diagnosis (n = 79 (23%)), they 
were managed without neoadjuvant chemotherapy (n = 7 (2%)), 
they had final surgery in another institution (n = 4 (1%)), they 
did not undergo surgical treatment (n = 9 (3%)), the follow-up 
was performed elsewhere (n = 13 (4%)), they were treated with 
rotationplasty (n = 4 (1%)), or they died from complications 
from chemotherapy (n = 1 (0.3%)).
Prognostic variables. The following data were extracted from 
the database: sex, age at diagnosis, primary tumour location, 
tumour size, histological subtype according to Fletcher’s clas-
sification,25 tumour stage (UICC, eighth edition),26 presence of 
pathological fractures, vascular proximity on the preoperative 
MRI after neoadjuvant chemotherapy, type of surgery (limb sal-
vage or amputation), surgical margin based on the Enneking sys-
tem (radical, wide, marginal, or intralesional),24 closest margin 
to the tumour, histological response to neoadjuvant chemother-
apy, presence or absence of vascular invasion, and oncological 
outcome including LRFS and overall survival (OS). The proto-
col of neoadjuvant chemotherapy was based on the European 
Osteosarcoma Intergroup (EOI) or European and American 
Osteosarcoma Studies (EURAMOS) trials.27,28 The vascular 
proximity was defined as the minimum distance between the 
tumour and the main vascular bundle. This distance was meas-
ured on the axial slices of preoperative T1-weighted MRI 
obtained during the periods between the last course of neoadju-
vant chemotherapy and surgical resection in order to eliminate 
possible oedema.29 Histological examination was performed by 
pathologists experienced in evaluating bone sarcomas. Micro-
scopic margins on the histological slides were measured in 
millimetres from the resection surface to the tumour. The his-
tological response was assessed in the resected specimen after 
surgery and chemotherapy-induced necrosis was reported as 
a percentage of the total tumour area. Patients were classified 
according to the necrosis rate as good responders (≥ 90% necro-
sis) and poor responders (< 90% necrosis). The necrosis was 
also subcategorized into four groups: grade 1 (< 50%), grade 
2 (50% to 89%), grade 3 (90% to 99%), and grade 4 (100%).30
Statistical analysis. All statistical analyses were performed 
using the SPSS statistical software (version 23; IBM Corp., 
Armonk, New York). OS was defined as the period from the 
date of diagnosis to the censored date of tumour-related death 
or last follow-up for survivors. LRFS was defined as the period 
from the date of diagnosis to the censored date of LR. OS and 
LRFS were estimated with the Kaplan–Meier method, and com-
parisons were assessed with the log-rank test. Multivariate anal-
ysis was conducted with the Cox proportional hazards model. 
p-values < 0.05 were considered to be statistically significant.
Results
Patient characteristics. A total of 226 participants matched 
the inclusion criteria. The clinicopathological characteristics of 
patients set are supplied in Supplementary Table i. The mean 
follow-up period was 61 months (6 to 120). Median age at diag-
nosis was 15 years (4 to 67) with the ratio of male to female 
patients being 1.5:1. The most common site of the tumour was 
the femur (n = 103 (46%)) followed by tibia (n = 66 (29%)). 
The median size of the tumour was 10.0 cm (2.3 to 28.8) and 
osteoblastic subtype was the most prevalent (58%). Pathologi-
cal fractures were identified in 28 patients (12%) who required 
cast immobilization or traction while undergoing preoperative 
chemotherapy. A total of 173 patients (77%) had limb- salvage 
surgery; 148 (65%) had endoprosthetic replacements; ten 
patients (4%) had simple excision of expendable bones with-
out reconstruction for example of the fibula or scapula. There 
were 53 amputations (23%). In terms of histological response 
to chemotherapy, 109 patients (48%) were good responders and 
117 patients (52%) were poor responders. Vascular invasion 
was present in 14 patients (6%).
Local control. The overall rate of LR was 8% (n = 19). The 
five-year and ten-year LRFS was 91% and 89%, respectively 
(Supplementary Fig. aa). Median LR-specific survival was 14 
months (6 to 83). Univariate log-rank analysis showed that sur-
gical margin, chemotherapy response, and presence of vascular 
invasion were factors significantly associated with an increased 
risk of LR (Supplementary Table i, Supplementary Fig. b). Mul-
tivariate analysis demonstrated significant associations between 
LR and response to neoadjuvant chemotherapy (chemotherapy 
necrosis < 90%, hazard ratio (HR) 5.52, 95% confidence inter-
val (CI) 1.58 to 19.25 vs chemotherapy necrosis ≥ 90%, HR 1; 
p = 0.007) and vascular invasion (present HR, 3.77; 95% CI, 
1.12 to 12.70 vs absent HR 1; p = 0.033) (Supplementary Table 
ii). Surgical margins stratified by the Enneking system did 
not reach statistical significance at multivariate analysis. Poor 
response to neoadjuvant chemotherapy was the most significant 
factor associated with LR.
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Overall survival. The five-year and ten-year OS for the patient 
cohort was 71% and 60%, respectively (Supplementary Fig. ab). 
Univariate analysis showed that sex, tumour stage, type of sur-
gery (limb salvage or amputation), surgical margin, response 
to neoadjuvant chemotherapy, presence of vascular invasion, 
and local recurrence were the significant prognostic factors that 
indicated a poor survival (Supplementary Table i, Supplemen-
tary Fig. c). Multivariate analyses using the Cox proportional 
hazard model demonstrated significant associations between 
tumour-related death and tumour stage IIB (HR 2.58; 95% CI, 
1.18 to 5.63 vs stage IIA HR 1; p = 0.017), < 90% chemotherapy 
necrosis (HR 2.44; 95% CI, 1.28 to 4.63 vs > 90% chemother-
apy necrosis HR 1; p = 0.006), and presence of LR (HR 4.43; 
95% CI, 2.21 to 8.89 vs absence of LR HR 1; p< 0.001) (Sup-
plementary Table ii). The other factors identified at univariate 
analysis did not reach statistical significance in the multivariate 
analysis.
Outcomes according to the vascular proximity. Based on the 
proximity of the tumour to the major vessels, 65 patients (29%) 
were type 1 (> 5 mm from the tumour), 86 patients (38%) type 
2 (≤ 5 mm from the tumour), 72 patients (32%) type 3 (attached 
to the tumour), and three patients (1%) type 4 (surrounded by 
the tumour) (Table I, Fig. 1). 
In type 1, five-year LRFS was 94% and five- and ten-year 
OS was 82% (Table I, Fig. 2). Limb salvage was performed in 
60 patients (92%) and amputation was performed in five (8%). 
The reasons for amputation included radical local control for a 
pathological fracture, patient’s decision for better postoperative 
function, or hemiplegia because of a central nervous system 
disorder. Surgical margin was radical in one patient (2%), wide 
in 57 patients (88%), and marginal in three patients (5%). In 
patients treated with limb salvage, the mean microscopic surgi-
cal margin to the major vascular bundle was 6.9 mm (1 to 20), 
and the mean closest margin in all directions was 5.4 mm (0.5 
to 34). LR was identified in four patients (6%); surgical margins 
were wide in three and marginal in one. No patient presented 
with LR from the perivascular area.
In type 2, LRFS at five-years was 94%, and then decreased 
slightly to 90% at ten years. The five- and ten-year OS was 
77% and 74%, respectively (Table I, Fig. 2). Limb salvage was 
Patterns of the proximity to the major vessels. Distance of the major vascular bundle (arrows) from the tumour was classified into four types: a) type 
1, > 5 mm; b) type 2, ≤ 5 mm and > 0 mm; c) type 3, attached to the tumour; and d) type 4, surrounded by the tumour.
Fig. 1a Fig. 1b Fig. 1c Fig. 1d
Table I. Clinical outcome based on the proximity between the tumours and the major vessels
Outcome Type 1 (> 5 mm) Type 2 (≤ 5 mm) Type 3 (attached) Type 4 (surrounded)
Patients, n (%) 65 (29) 86 (38) 72 (32) 3 (1)
Type of surgery, n (%)
Limb-salvage surgery 60 (92) 76 (88) 37 (51) 0 (0)
Amputation 5 (8) 10 (12) 35 (49) 3 (100)
Surgical margin, n (%)
Radical 1 (2) 2 (2) 15 (21) 2 (67)
Wide 57 (88) 59 (69) 34 (47) 1 (33)
Marginal 3 (5) 22 (26) 21 (29) 0 (0)
Intralesional 0 (0) 1 (1) 2 (3) 0 (0)
Mean microscopic distance (in patients with  
limb-salvage surgery), mm
Distance to the direction of the vessel 6.9 3.0 1.4 N/A
Closest margin to any directions 5.4 2.3 1.3 N/A
Local recurrence, n (%)
Total 4 (6) 6 (7) 9 (13) 0 (0)
Perivascular area per total of local recurrence 0 (0) 1 (1) 3 (4) N/A
Five-year survival (%)
Local recurrence-free survival 94 94 86 100
Overall survival 82 77 57 67
N/A, not applicable
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performed in 76 patients (88%) and amputation in ten (12%). The 
reasons for amputation were concurrent fracture in the affected 
limb, unrelated to the oncological condition, the patient’s deci-
sion, pathological fracture, or progressive disease during neo-
adjuvant chemotherapy. Surgical margins were radical in two 
patients (2%), wide in 59 patients (69%), marginal in 22 patients 
(26%), and intralesional in one patient (1%). Patients treated 
with limb salvage had a mean microscopic surgical margin to the 
major vascular bundle of 3.0 mm (0 to 6), while the mean closest 
margin in all directions was 2.3 mm (0 to 10). LR was identi-
fied in six patients (7%), of which surgical margins were wide 
in three and marginal in three. One patient who had a marginal 
surgical excision presented with LR within the perivascular area.
In type 3, five-year LRFS was 86% and five- and ten-year 
OS was 57% and 30%, respectively. These survival rates were 
the lowest ones observed in all types (Table I, Fig. 2). A total 
of 37 patients (51%) underwent limb-sparing surgery and 25 
(49%) underwent amputation. The surgical margins were rad-
ical in 15 patients (21%), wide in 34 (47%), marginal in 21 
(29%), and intralesional in two (3%). Despite the observation 
of the tumours being attached to the major vascular bundles in 
preoperative MRIs, the actual mean microscopic surgical mar-
gin to the major vascular bundles in patients treated with limb 
salvage was 1.4 mm (0 to 3) (Table I, Supplementary Fig. d), 
while the mean closest margin in all directions was 1.3 mm (0 to 
2). LR was identified in nine patients (13%); the surgical mar-
gins were wide in two, marginal in six, and intralesional in one. 
Three patients with a marginal margin developed LR within the 
perivascular area.
In type 4, all patients underwent amputation. No patients 
experienced LR, while five-year OS was 67% (Table I, Fig. 2). 
Surgical margin was radical in two patients (67%) and wide in 
one patient (33%).
Comparing the LRFS in all groups, patients treated with 
limb-salvage surgery and classified as type 3 had a significantly 
lower survival than patients categorized as type 1 or type 2 
(Fig. 2a; log-rank test, p = 0.030). No statistical differences were 
observed in patients treated with amputation (Supplementary 
Fig. e; p = 0.433). The Kaplan–Meier analysis for OS illustrated 
the significant spread between the categories (Fig. 2b; p < 0.001). 
Type 3 patients had a significantly poorer survival compared 
with the other types (type 3 HR, 3.22; 95% CI 1.53 to 6.75 ver-
sus type 1 HR, 1; p = 0.002) (Supplementary Table ii), although 
no significance was reached in the multivariate analysis.
In a subgroup analysis based on the tumour sites, the poor-
est LRFS was also seen in type 3 patients who had tibial and 
humeral tumours (Supplementary Fig. f). Patients with femoral 
tumours had similar recurrence rates regardless of the type of 
vascular proximity. In patients with tumours of the distal femur 
and proximal tibia, the lowest LRFS was recorded in type 3, 
followed by type 2 and 1 (Supplementary Fig. f). The Kaplan–
Meier curves for OS showed the poorest prognosis in type 3 
in all tumour sites, with statistical significance in patients with 
tumours in the distal femur (p = 0.013) and the proximal tibia 
(p = 0.043) (Supplementary Fig. f).
Analyzing the outcome in type 3 patients according to the 
surgical treatment, the Kaplan–Meier curve analysis for LRFS 
illustrated a significant spread according to the surgical man-
agement performed. The five-year LRFS were 96% in patients 
treated with amputations and 76% in those with limb-sparing 
surgery (Fig. 3a; log-rank test, p = 0.025). Patients with limb 
salvage were eight times more likely to develop LR than those 
treated with amputation (HR 8.05; 95% CI 1.01 to 64.39 vs HR, 
1; p = 0.049). No statistical difference in OS were identified in 
type 3 patients between amputation and limb- sparing surgery 
(Fig. 3b; log-rank test, p = 0.842).
Among type 3 patients with limb-salvage surgery, a clear 
difference in LRFS was observed between good and poor 
responders to neoadjuvant chemotherapy with no LR in those 
who had a 100% necrosis rate (Supplementary Fig. g). No 
Kaplan–Meier curves for: a) local recurrence (LR)-free survival in patients with limb-salvage surgery; and b) overall survival 
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statistical difference in LRFS was observed when comparing 
patients treated with limb salvage who responded to chemo-
therapy and patients managed with amputation (Fig. 4a; log-
rank test, p = 0.290). With regard to the patterns of vascular 
attachment, LRFS was poorer in patients with the vascular 
attachment over half of the circumference of the major vascular 
bundle on the axial MRI (Supplementary Fig. ha; log-rank test, 
p < 0.001). Furthermore, patients who had vascular attachment 
less than 10 mm longitudinally had no LR (Supplementary 
Fig. hb; log-rank test, p = 0.025). The Kaplan–Meier analysis 
for LRFS showed a significant difference between patients with 
limited vascular attachment (< 50% of the circumference or < 
10 mm longitudinally) to those with wider attachment (Fig. 4b; 
log-rank test, p = 0.025). These data demonstrated that, while 
amputation offered better local control with no survival bene-
fit in type 3, the risk of LR by limb salvage was lower if the 
tumour responded to neoadjuvant chemotherapy or the vascu-
lar attachment was limited.
Discussion
The distance between the tumours and the major vessels is one 
of the most important factors for surgeons to consider when 
Kaplan–Meier curves for: a) local recurrence (LR)-free survival; and b) overall survival in type 3 patients stratified by the nature of  













































































Fig. 3a Fig. 3b
Kaplan–Meier curves for local recurrence-free survival in type 3 patients stratified by: a) the nature of surgery and response to 
neoadjuvant  chemotherapy; and b) the patterns of attachment between the tumour and the major vessels in patients with limb 
 salvage. *p = 0.009; †p = 0.025.
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treating patients with osteosarcoma. Although many authors 
have studied the prognostic factors for LRFS or OS in osteo-
sarcoma,1,8,9,15-22,24,31-37 there has been no study focusing specif-
ically on the prognostic significance of the vascular proximity 
of the tumour. Previous studies have demonstrated that the most 
important predictive factors regarding LR were poor response to 
neoadjuvant chemotherapy and inadequate surgical margins,21,22 
and those regarding OS were age, tumour size, tumour location, 
response to neoadjuvant chemotherapy, and pathological frac-
ture.8,15-20,35 However, several discrepancies have been observed 
between the various cohorts studied21,22,31,32,37 and Bramer et al35 
concluded that this might be explained by methodological 
issues. In our study, the most important prognostic factors for 
LRFS were the tumour’s response to neoadjuvant chemother-
apy and also the presence of vascular invasion. Tumour stage, 
response to neoadjuvant chemotherapy, presence of local recur-
rence, and development of metastasis were all prognostic fac-
tors for OS, and were consistent with the previous reports.24,35 
The proportion of patients presenting with LR (8%) and five- 
and ten-year OS (71% and 60%) in our cohort was comparable 
to that of previous studies.8,21,28,32 In terms of vascular proximity 
of the tumour, LRFS and OS decreased as the distance between 
the tumour and the major vasculature reduced, although the 
difference was not statistically significant in LRFS because 
of a relatively small number of LR in our cohort. This result 
confirms that an adequate margin of resection is required in all 
directions in order to obtain local control. However, it should be 
noted that LR incidence from the perivascular area increased as 
the tumours approached the major vessels.
We have evaluated the correlation between the vascular prox-
imity on preoperative MRI and the microscopic surgical margin 
to the major vessels. The mean microscopic margin in type 3 
was 1.4 mm in patients with limb salvage, which suggests that 
normal soft tissues were present between the tumour and the 
major vessels, even if they appeared to be attached on MRI. van 
Trommel et al29 compared the vascular involvement on preop-
erative MRI and the postoperative pathological findings. They 
found that among 13 patients whose MRI showed equivocal 
findings for major vascular involvement of the tumour, none 
was found to have histopathological involvement. Although no 
further pathological details were reported in their paper, a vas-
cular sheath or adipose tissue between the tumour and the major 
vessels might well be present, which Kawaguchi et al38 argued 
was a thin barrier comprising of a 2 cm thickness of normal 
tissue.
Based on the Birmingham Classification,24 the strongest pre-
dictor of LR was a combination of margins ≤ 2 mm and a necro-
sis rate of less than 90%, with the risk of LR as 24% at five years. 
While this classification can provide a confident prediction of the 
prognosis based upon the postoperative histopathology, our study 
provides a prognostic prediction based on preoperative MRI data. 
Since the microscopic margin of all patients with limb salvage in 
type 3 were less than 2 mm, they can be classified as type 1b or 
2b using the Birmingham Classification, which means that the 
risk of LR is at least 8% or 24% in five years, respectively.24 In 
our study, the risk of LR in type 3 patients with limb salvage sur-
gery was 13% in good responders and 33% in poor responders, 
which confirms our previous finding that chemotherapy response 
was a very strong predictor for LR. The problem arises, however, 
regarding how possible it is to predict tumour response to neo-
adjuvant chemotherapy preoperatively. Recent reports that may 
help in this prediction and in surgical planning have reported 
the efficacy of functional imaging, such as phase contrast-en-
hancement MRI39, or 2-(fluorine-18)-fluoro-2-deoxy-D-glucose 
(FDG) positron emission tomography (PET)-CT scan,40. 
There are several limitations to our study. First, the quality 
of the MRI was not always consistent between patients. Our 
institute is a major referral centre and MRI were sometimes 
obtained at different local hospitals, which may induce error in 
assessment of the parameters. Second, there is no formal corre-
lation available to verify preoperative MRI measurements with 
measured surgical margins, which could lead to a discrepancy 
in the results. Third, the interpretation of the surgical margin, 
as defined by Enneking et al,24 was subjective and might vary 
depending on who undertook the assessment. For that reason, 
we applied a clearly defined microscopic margin measured in 
millimetres, which was objective and reproducible. Fourth, our 
study did not describe the functional outcomes based on the 
type of surgery performed. Finally, this was a single-institution 
retrospective study and future multicentre studies could offer 
useful prognostic information.
In summary, on the basis of a relatively large series of 226 
patients with osteosarcoma of the limbs, we have demonstrated 
the clinicopathological significance of the proximity to the 
major vessels and clarified the outcome based on the type of 
surgery and the proximity of the tumour to these vessels. We 
found that there was an increased risk of LR and decreased 
OS as the tumour became close to the major vessels. When the 
tumour was observed to be attached to a major vascular bundle 
on preoperative MRI, amputation offered better local control, 
despite no survival benefit. However, the risks of LR by limb 
salvage was lower if patients are good responders to neoadju-
vant treatment, or the vascular attachment is limited to 10 mm 
longitudinally or half the circumference of the vascular bundle. 
We believe that these findings could offer useful prognostic 
information for treating oncologists and be helpful in advising 
patients on the management of their osteosarcoma.
Take home message
- The proximity of osteosarcoma to major blood vessels is a 
poor prognostic factor for local control and survival.
- Amputation offers better local control for tumours attached to the blood 
vessels but does not improve survival.
- Limb salvage surgery offers similar local control if the radiological at-
tachment of the tumour to major blood vessels is limited.
Supplementary material
Further Kaplan–Meier curves, as well as a table showing 
patient characteristics and univariate analysis for local 
recurrence-free survival (LRFS) and overall survival (OS).
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